Table 1.
Comparison of clinical characteristics between OC patients and control group
| Variables | EOC (n=587) | Control (n=650) | P |
|---|---|---|---|
| Age (years, mean ± SD) | 58.97±8.71 | 58.31±10.18 | 0.22 |
| <60 | 336 (51.69%) | 384 (59.08%) | 0.51 |
| ≥60 | 251 (38.62%) | 266 (40.92%) | |
| BMI (kg/m2, n (%)) | 25.44±2.15 | 25.39±2.13 | 0.68 |
| <24 | 164 (27.94%) | 197 (30.31%) | 0.36 |
| ≥24 | 423 (72.06%) | 453 (69.69%) | |
| Number live-born (n (%)) | |||
| 0 | 47 (8.01%) | 45 (6.92%) | 0.31 |
| 1~2 | 364 (62.01%) | 430 (66.15%) | |
| ≥3 | 176 (29.98%) | 175 (26.92%) | |
| Smoking (n (%)) | |||
| Yes | 100 (17.04%) | 114 (17.54%) | 0.82 |
| No | 487 (82.96%) | 536 (82.46%) | |
| Drinking (n (%)) | |||
| Yes | 96 (16.35%) | 98 (15.08%) | 0.54 |
| No | 491 (83.65%) | 552 (84.92%) | |
| OC family history (n (%)) | |||
| Yes | 94 (16.01%) | 22 (3.38%) | <0.01 |
| No | 493 (83.99%) | 628 (96.62%) | |
| FIGO stage (n (%)) | |||
| I | 104 (17.72%) | ||
| II | 121 (20.61%) | ||
| III | 293 (49.91%) | ||
| IV | 69 (11.75%) | ||
| Tumor grade (n (%)) | |||
| G1 | 59 (10.05%) | ||
| G2 | 168 (28.62%) | ||
| G3 | 360 (61.33%) | ||
| Lymphatic metastasis (n (%)) | |||
| Yes | 364 (62.01%) | ||
| No | 223 (37.99%) | ||
BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics